Skip to main content
Log in

Psoriasis and IgE-mediated allergy: correlation or mutual inhibition?

A prospective cohort study in patients with mild or moderate to severe psoriasis

  • original article
  • Published:
Wiener klinische Wochenschrift Aims and scope Submit manuscript

Summary

Background

Psoriasis is an autoimmune disease caused by overactivation of TH1 (Type 1 helper cells) and TH17 (T helper 17) cells. Overactivation of TH1 cells inhibits the activity of TH2 cells involved in type 1 allergies, therefore, psoriasis patients might be less affected by type 1 allergies. This study tested if allergies were less frequent in patients with moderate to severe than with mild psoriasis.

Methods

Psoriasis patients at the study site reported possible allergy symptoms and were tested for common allergens by skin prick test and IgE levels. Psoriasis was classified by PASI scores (Psoriasis Area and Severity Index) as mild (PASI <10) or moderate/severe (PASI ≥10). Patients without systemic therapy were assessed separately. Fisher’s exact test was used to test for differences.

Results

A total of 97 patients were included, 21 with mild and 76 with moderate to severe psoriasis. Allergies were found in 27.8%, most commonly against dust mites (23.4%) and grasses (18.1%). Allergies were found in 23.8% of the patients with mild vs. 29.0% allergic patients with moderate to severe psoriasis (P = 0.786). In patients without systemic medication, allergies were found in 21.1% vs. 35.3% (P = 0.463).

Conclusion

Allergy prevalence was not reduced in patients with moderate/severe psoriasis, and generally close to the prevalence in the general Austrian population (24%). The inhibiting effect of psoriasis on type 1 allergies was not confirmed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

Cited Literature

  1. Patel AB, Tsilioni I, Weng Z, Theoharides TC. TNF stimulates IL‑6, CXCL8 and VEGF secretion from human keratinocytes via activation of mTOR, inhibited by tetramethoxyluteolin. Exp Dermatol. 2018;27:135–43. https://doi.org/10.1111/exd.13461.

    Article  CAS  PubMed  Google Scholar 

  2. Mansouri Y, Goldenberg G. Biologic safety in psoriasis: review of long-term safety data. J Clin Aesthet Dermatol. 2015;8:30–42.

    PubMed  PubMed Central  Google Scholar 

  3. Blumenthal-Barby E. Charakterisierung einer humanen endogenen retroviralen dUTPase als Suszeptibilitätsgen für Psoriasis vulgaris: [Characterization of a human endogenous retroviral dUTPase as susceptibility gene for psoriasis vulgaris] [PhD Thesis]. Berlin: Universitätsmedizin Berlin; 2012.

  4. Nair RP, Stuart PE, Nistor I, Hiremagalore R, Chia NVC, Jenisch S, et al. Sequence and haplotype analysis supports HLA‑C as the psoriasis susceptibility 1 gene. Am J Hum Genet. 2006;78:827–51. https://doi.org/10.1086/503821.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Guttman-Yassky E, Krueger JG. Atopic dermatitis and psoriasis: two different immune diseases or one spectrum? Curr Opin Immunol. 2017;48:68–73. https://doi.org/10.1016/j.coi.2017.08.008.

    Article  CAS  PubMed  Google Scholar 

  6. Chiricozzi A, Suárez-Fariñas M, Fuentes-Duculan J, Cueto I, Li K, Tian S, et al. Increased expression of interleukin-17 pathway genes in nonlesional skin of moderate-to-severe psoriasis vulgaris. Br J Dermatol. 2016;174:136–45. https://doi.org/10.1111/bjd.14034.

    Article  CAS  PubMed  Google Scholar 

  7. Kreft S, Kreft M, Resman A, Marko P, Kreft KZ. Computer-aided measurement of psoriatic lesion area in a multicenter clinical trial—comparison to physician’s estimations. J Dermatol Sci. 2006;44:21–7. https://doi.org/10.1016/j.jdermsci.2006.05.006.

    Article  PubMed  Google Scholar 

  8. Langen U, Schmitz R, Steppuhn H. Häufigkeit allergischer Erkrankungen in Deutschland: Ergebnisse der Studie zur Gesundheit Erwachsener in Deutschland (DEGS1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013;56:698–706. https://doi.org/10.1007/s00103-012-1652-7.

    Article  CAS  PubMed  Google Scholar 

  9. Maucher J. Erster österreichischer Allergiebericht: Einschätzung und Realität unterschiedlich. Osterr Arzteztg. 2006;11:56–7.

    Google Scholar 

  10. Averbeck M, Gebhardt C, Emmrich F, Treudler R, Simon JC. Immunologic principles of allergic disease. J Dtsch Dermatol Ges. 2007;5:1015–28. https://doi.org/10.1111/j.1610-0387.2007.06538.x.

    Article  PubMed  Google Scholar 

  11. Benn CS, Bendixen M, Krause TG, Olesen AB. Questionable coexistence of T(H)1- and T(H)2-related diseases. J Allergy Clin Immunol. 2002;110:328–9. author reply 329–30.

    Article  Google Scholar 

  12. Graham-Rowe D. Lifestyle: When allergies got west. Nature. 2011;479:S2–S4.

    Article  Google Scholar 

  13. Oriss TB, McCarthy SA, Morel BF, Campana MA, Morel PA. Crossregulation between T helper cell (Th)1 and Th2: Inhibition of Th2 proliferation by IFN-gamma involves interference with IL‑1. J Immunol. 1997;158:3666–72.

    CAS  PubMed  Google Scholar 

  14. Christophers E. Psoriasis—epidemiology and clinical spectrum. Clin Exp Dermatol. 2001;26:314–20.

    Article  CAS  Google Scholar 

  15. Hajdarbegovic E, Nijsten T, Westgeest A, Habraken F, Hollestein L, Thio B. Decreased prevalence of atopic features in patients with psoriatic arthritis, but not in psoriasis vulgaris. J Am Acad Dermatol. 2013;68:270–7. https://doi.org/10.1016/j.jaad.2012.07.018.

    Article  PubMed  Google Scholar 

  16. Mrowietz U, Kragballe K, Reich K, Spuls P, Griffiths CE, Nast A, et al. Definition of treatment goals for moderate to severe psoriasis: A European consensus. Arch Dermatol Res. 2011;303:1–10.

    Article  CAS  Google Scholar 

  17. Ruëff F, Bergmann K‑C, Brockow K, Fuchs T, Grübl A, Jung K, et al. Hauttests zur Diagnostik von allergischen Soforttypreaktionen: Leitlinie der Deutschen Gesellschaft für Allergologie und klinischen Immunologie (DGAKI). Pneumologie. 2011;65:484–95.

    Article  Google Scholar 

  18. Bernstein IL, Li JT, Bernstein DI, Hamilton R, Spector SL, Tan R, et al. Allergy diagnostic testing: An updated practice parameter. Ann Allergy Asthma Immunol. 2008;100:S1–S148.

    Article  CAS  Google Scholar 

  19. Kleine-Tebbe J, Ballmer-Weber B, Beyer K, Erdmann S, Fuchs T, Henzgen M, et al. In-vitro-Diagnostik und molekulare Grundlagen von IgE-vermittelten Nahrungsmittelallergien: Leitlinie der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAKI), des Ärzteverbandes Deutscher Allergologen (ÄDA), der Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA), der Österreichischen Gesellschaft für Allergologie und Immunologie (ÖGAI) und der Schweizerischen Gesellschaft für Allergologie und Immunologie (SGAI). Allergo J. 2009;18:132–46.

    Google Scholar 

  20. Griebler R, Winkler P, Gaiswinkler S, Delcour J, Jusaszovich B, Nowotny M, et al. Österreichischer Gesundheitsbericht 2016 [Austrian health report 2016]. 2017. Berichtszeitraum 2005–2014/15.

    Google Scholar 

  21. Dittmar D, Uter W, Bauer A, Fortina AB, Bircher AJ, Czarnecka-Operacz M, et al. European Surveillance System on Contact Allergies (ESSCA): polysensitization, 2009–2014. Contact Derm. 2018;78:373–85. https://doi.org/10.1111/cod.12966.

    Article  Google Scholar 

  22. Österreichische Gesellschaft für Pneumologie.. Klimawandel verstärkt Risiko für Allergien und Asthma: Klimawandel und die Folgen für die Lungengesundheit – Ergebnisse aus der LEAD-Studie. Wien: ÖGP; 2017.

    Google Scholar 

  23. Asher MI, Montefort S, Björkstén B, Lai CKW, Strachan DP, Weiland SK, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet. 2006;368:733–43. https://doi.org/10.1016/S0140-6736(06)69283-0.

    Article  PubMed  Google Scholar 

  24. Schernhammer ES, Vutuc C, Waldhör T, Haidinger G. Time trends of the prevalence of asthma and allergic disease in Austrian children. Pediatr Allergy Immunol. 2008;19:125–31. https://doi.org/10.1111/j.1399-3038.2007.00597.x.

    Article  CAS  PubMed  Google Scholar 

  25. Bjerg A, Sandström T, Lundbäck B, Rönmark E. Time trends in asthma and wheeze in Swedish children 1996–2006: prevalence and risk factors by sex. Allergy. 2010;65:48–55. https://doi.org/10.1111/j.1398-9995.2009.02105.x.

    Article  PubMed  Google Scholar 

  26. Zöllner IK, Weiland SK, Piechotowski I, Gabrio T, von Mutius E, Link B, et al. No increase in the prevalence of asthma, allergies, and atopic sensitisation among children in Germany: 1992-2001. Thorax. 2005;60:545–8. https://doi.org/10.1136/thx.2004.029561.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Pigatto PD. Atopy and contact sensitization in psoriasis. Acta Derm Venereol Suppl (Stockh). 2000;80:19–20.

    Article  Google Scholar 

  28. Chen C, Zheng X, Duan Q, Yang P, Zheng Y. High serum IgE concentration in patients with psoriasis. Clin Res Dermatol. 2017;4:1–4.

    Google Scholar 

  29. Skaaby T, Husemoen LLN, Thuesen BH, Fenger RV, Linneberg A. Specific IgE positivity against inhalant allergens and development of autoimmune disease. Autoimmunity. 2015;48:282–8. https://doi.org/10.3109/08916934.2014.1003640.

    Article  CAS  PubMed  Google Scholar 

  30. Rabin RL, Levinson AI. The nexus between atopic disease and autoimmunity: a review of the epidemiological and mechanistic literature. Clin Exp Immunol. 2008;153:19–30. https://doi.org/10.1111/j.1365-2249.2008.03679.x.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Yan K‑X, Huang Q, Fang X, Zhang Z‑H, Han L, Gadaldi K, et al. IgE and FcεRI are highly expressed on innate cells in psoriasis. Br J Dermatol. 2016;175:122–33. https://doi.org/10.1111/bjd.14459.

    Article  CAS  PubMed  Google Scholar 

  32. Gruber S, Tiringer K, Dehlink E, Eiwegger T, Mayer E, Konstantin H, et al. Allergic sensitization in kidney-transplanted patients prevails under tacrolimus treatment. Clin Exp Allergy. 2011;41:1125–32. https://doi.org/10.1111/j.1365-2222.2011.03761.x.

    Article  CAS  PubMed  Google Scholar 

  33. Ozdemir O. New developments in transplant-acquired allergies. World J Transplant. 2013;3:30–5. https://doi.org/10.5500/wjt.v3.i3.30.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Bandelier C, Leimgruber A, Wassenberg J, Bart PA, Spertini F. Allergies alimentaires rares. Rev Med Suisse. 2008;4:1024–9.

    CAS  PubMed  Google Scholar 

  35. Wassenberg J, Bart PA. Modern nutrition and development of new allergies. Rev Med Suisse. 2007;3:1032–7.

    CAS  PubMed  Google Scholar 

  36. Schernhammer ES, Vutuc C, Waldhör T, Haidinger G. Time trends of the prevalence of asthma and allergic disease in Austrian children. Pediatric Allergy and Immunology. 2008;19(2):125–131

    Article  CAS  Google Scholar 

  37. de Vos G, Nazari R, Ferastraoaru D, Parikh P, Geliebter R, Pichardo Y, et al. Discordance between aeroallergen specific serum IgE and skin testing in children younger than 4 years. Ann Allergy Asthma Immunol. 2013;110:438–43. https://doi.org/10.1016/j.anai.2013.03.006.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Bergmann K‑C. Current status of allergy prevalence in Germany: Position paper of the Environmental Medicine Commission of the Robert Koch Institute. 2016.

    Book  Google Scholar 

  39. Essl A. Vergleich der Prävalenz von IGE-vermittelten Sensibilisierungen und Allergien bei Patienten mit leichter (PASO 〈 10) und schwerer (PASI 〉 10) Psoriasis vulgaris: [Comparison of the prevalence of IgE mediated sensibilisation and allergy in patients with mild (PASI 〈 10) and severe (PASI 〉 10) psoriasis vulgaris] [Thesis]. Vienna: Medical University Vienna; 2018.

Further Reading

  1. Eyerich S, Onken AT, Weidinger S, Franke A, Nasorri F, Pennino D, et al. Mutual antagonism of T cells causing psoriasis and atopic eczema. N Engl J Med. 2011;365:231–8. https://doi.org/10.1056/NEJMoa1104200.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

These results were first presented as A. Essl’s thesis [39], supervised by D. Loader and P. Sator. Writing assistance was provided by W. Adlassnig (CW Research and Management GmbH).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Paul Sator.

Ethics declarations

Conflict of interest

A. Essl, D. Loader, R. Feldmann, A. Steiner, and P. Sator declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Caption Electronic Supplementary Material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Essl, A., Loader, D., Feldmann, R. et al. Psoriasis and IgE-mediated allergy: correlation or mutual inhibition?. Wien Klin Wochenschr 133, 997–1003 (2021). https://doi.org/10.1007/s00508-020-01683-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00508-020-01683-0

Keywords

Navigation